Biotech company enters million-dollar contract with US government
Meabco has managed to get through the eye of the needle at the governmental US health institute NIAID, and will receive DKK 40 million (USD 5.9 million) for the development of its treatment for radiation damage. Now, the company wants to raise fresh capital.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.